SCOTTSDALE, Ariz., April 02, 2026--(BUSINESS WIRE)--Tenpoint Therapeutics, a leading ophthalmic manufacturer, and PHIL Inc., an all-in-one digital hub and Direct-to-Patient platform, today announced ...
The MarketWatch News Department was not involved in the creation of this content. BOSTON, April 16, 2026 /PRNewswire/ -- The Digital Medicine Society (DiMe) today announced the launch of a new ...
“Disconnected and fragmented” healthcare experiences -- such as prior authorization requirements and product accessibility issues -- are reducing the effectiveness of consumer ad spend, according to ...
TrumpRx lowers drug prices but doesn't address diagnosis and care access barriers, limiting its impact on patient outcomes. Pharma must develop DTP programs integrating education, testing, and ...
MANILA, Philippines—Globe has expanded its cyber safety advocacy beyond major urban centers, bringing its Digital Thumbprint ...
BOSTON, April 16, 2026 /PRNewswire/ -- The Digital Medicine Society (DiMe) today announced the launch of a new pre-competitive initiative, Optimizing Direct-to-Patient (DTP) Strategies for Pharma, ...
Tenpoint Therapeutics Ltd and PHIL Partner to Launch YUVEZZI™ Direct-to-Patient Cash Program to Make Novel Presbyopia Therapy More Accessible and Affordable Tenpoint Therapeutics, a leading ophthalmic ...